Fresenius Medical Care AG & Co. KGaA revised earnings guidance for the financial year 2022. For the year, the company now assumes lower contributions in the financial year 2022.

Consequently, the company now expects net income (attributable to shareholders of Fresenius Medical Care AG & Co. KGaA) for the financial year 2022 to decline in the high teens to mid-twenties percentage range. The Company continues to anticipate revenue to grow at a low-single digit percentage range in the financial year 2022.

These targets are in constant currency and exclude special items.